Published in Blood on November 22, 2005
The role of the anaphylatoxins in health and disease. Mol Immunol (2009) 2.95
Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol (2007) 1.59
Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes (2010) 1.57
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med (2013) 1.48
Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol (2008) 1.28
The role of complement in the early immune response to transplantation. Nat Rev Immunol (2012) 1.26
New concepts of complement in allorecognition and graft rejection. Cell Immunol (2007) 1.02
Role and mechanism of action of complement in regulating T cell immunity. Mol Immunol (2010) 0.97
Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol (2011) 0.96
C-reactive protein-mediated vascular injury requires complement. Arterioscler Thromb Vasc Biol (2010) 0.96
C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection. J Immunol (2009) 0.95
Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity. J Immunol (2007) 0.93
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood (2013) 0.92
Immune modulation of vascular resident cells by Axl orchestrates carotid intima-media thickening. Am J Pathol (2012) 0.90
The complement cascade and renal disease. Arch Immunol Ther Exp (Warsz) (2013) 0.90
C5aR expression in a novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity. J Immunol (2012) 0.89
The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am J Pathol (2009) 0.88
Complement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection. PLoS Pathog (2013) 0.88
Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation. Clin J Am Soc Nephrol (2012) 0.86
Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol (2012) 0.85
Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement. PLoS One (2011) 0.83
Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection. Immunobiology (2016) 0.82
Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation. Biol Blood Marrow Transplant (2012) 0.81
Complement anaphylatoxins as immune regulators in cancer. Cancer Med (2014) 0.79
The innate immune system and transplantation. Cold Spring Harb Perspect Med (2013) 0.79
APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model. Br J Pharmacol (2016) 0.76
Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant. Am J Transplant (2015) 0.76
Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ. Eur J Immunol (2017) 0.75
Complement Component C4 Regulates the Development of Experimental Autoimmune Uveitis through a T Cell-Intrinsic Mechanism. Front Immunol (2017) 0.75
Complement Recognition Pathways in Renal Transplantation. J Am Soc Nephrol (2017) 0.75
Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2015) 4.11
Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst (2003) 3.65
Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med (2002) 3.39
Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem (2010) 2.34
Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell (2013) 2.17
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res (2002) 2.02
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med (2011) 1.97
Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem (2005) 1.97
Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med (2006) 1.97
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest (2008) 1.94
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med (2003) 1.92
Bis[1,3-bis-(1-benzyl-1H-benzimidazol-2-yl)-2-oxapropane]nickel(II) dipicrate-dimethyl-formamide-ethanol (1/2/0.25). Acta Crystallogr Sect E Struct Rep Online (2009) 1.89
Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol (2006) 1.87
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85
Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int (2010) 1.83
Bis[1,3-bis-(1-benzyl-1H-benzimidazol-2-yl)-2-oxapropane]zinc(II) dipicrate dimethyl-formamide disolvate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.76
A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab (2010) 1.69
Total synthesis of dimeric pyrrole-imidazole alkaloids: sceptrin, ageliferin, nagelamide e, oxysceptrin, nakamuric acid, and the axinellamine carbon skeleton. J Am Chem Soc (2007) 1.65
Recent patterns in population-based HIV prevalence in Swaziland. PLoS One (2013) 1.58
Acupoint-specific fMRI patterns in human brain. Neurosci Lett (2005) 1.57
Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol (2006) 1.57
The salient characteristics of the central effects of acupuncture needling: limbic-paralimbic-neocortical network modulation. Hum Brain Mapp (2009) 1.55
Protein farnesyltransferase and protein prenylation in Plasmodium falciparum. J Biol Chem (2002) 1.52
Functional magnetic resonance imaging activation of the brain in children: real acupoint versus sham acupoint. J Child Neurol (2010) 1.51
Effect of acupuncture on the brain in children with spastic cerebral palsy using functional neuroimaging (FMRI). J Child Neurol (2008) 1.51
Dried tube specimens: a simple and cost-effective method for preparation of HIV proficiency testing panels and quality control materials for use in resource-limited settings. J Virol Methods (2009) 1.48
Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. J Clin Invest (2016) 1.43
Effects of doctor-patient communication on quality of life among breast cancer patients in southern China. Asian Pac J Cancer Prev (2014) 1.41
Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol (2004) 1.40
Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med (2002) 1.40
Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J (2006) 1.38
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood (2007) 1.37
Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood (2008) 1.33
The retromer component SNX6 interacts with dynactin p150(Glued) and mediates endosome-to-TGN transport. Cell Res (2009) 1.33
Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.28
Multi-angle ratiometric approach to measure chemical exchange in amide proton transfer imaging. Magn Reson Med (2011) 1.28
Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol (2007) 1.27
Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell (2013) 1.25
Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol (2009) 1.24
β-catenin as a potential key target for tumor suppression. Int J Cancer (2011) 1.23
Aqua-[1,3-bis-(benzimidazol-2-yl)-2-oxapropane]-diethano-lmanganese(II) dipicrate ethanol disolvate. Acta Crystallogr Sect E Struct Rep Online (2010) 1.22
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis (2008) 1.22
Unusual microbial xylanases from insect guts. Appl Environ Microbiol (2004) 1.22
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets (2009) 1.22
Proposal of a quality-index or metric for soft copy display systems: contrast sensitivity study. J Digit Imaging (2003) 1.20
Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J Immunol (2008) 1.20
PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Mol Cancer Ther (2003) 1.19
Coronary sinus septal defect (unroofed coronary sinus): echocardiographic diagnosis and surgical treatment. Int J Cardiol (2012) 1.18
Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol (2008) 1.17
Optimizing pulsed-chemical exchange saturation transfer imaging sequences. Magn Reson Med (2011) 1.16
Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images. Neuroimage (2009) 1.15
High-quality gene assembly directly from unpurified mixtures of microarray-synthesized oligonucleotides. Nucleic Acids Res (2010) 1.14
Scaling law for noise variance and spatial resolution in differential phase contrast computed tomography. Med Phys (2011) 1.13
Short, enantioselective total synthesis of sceptrin and ageliferin by programmed oxaquadricyclane fragmentation. Angew Chem Int Ed Engl (2005) 1.13
CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther (2012) 1.12
TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol (2006) 1.12
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11
Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice. Hepatology (2013) 1.11
Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology (2005) 1.10
Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease. J Neurosci (2011) 1.09
Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J (2011) 1.08
Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes (2012) 1.08
Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J Am Soc Nephrol (2006) 1.08
Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease. Hum Mol Genet (2013) 1.08
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res (2009) 1.08
Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. Mol Immunol (2011) 1.06
Synthesis and anti-tumor activity of novel ethyl 3-aryl-4-oxo-3,3a,4,6-tetrahydro-1H-furo[3,4-c]pyran-3a-carboxylates. Bioorg Med Chem Lett (2011) 1.06
Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol (2006) 1.06
An interactive method of assessing the characteristics of softcopy display using observer performance tests. J Digit Imaging (2002) 1.06
Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol (2007) 1.06
Multicontrast x-ray computed tomography imaging using Talbot-Lau interferometry without phase stepping. Med Phys (2012) 1.06
Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model. Neuroimage (2011) 1.05
Trends in esophageal cancer mortality in China during 1987-2009: age, period and birth cohort analyzes. Cancer Epidemiol (2012) 1.05
Characterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopy. PLoS One (2012) 1.05
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease. Neurobiol Dis (2008) 1.05
Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J Neurochem (2012) 1.05
C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 1.05
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J Nanopart Res (2010) 1.04
Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer (2007) 1.03
Mechanisms of disease: the complement system in renal injury--new ways of looking at an old foe. Nat Clin Pract Nephrol (2007) 1.03
trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J Biol Chem (2012) 1.02
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. Neuroimage (2013) 1.01
Sir2 deletion prevents lifespan extension in 32 long-lived mutants. Aging Cell (2011) 1.01
The use of eculizumab in renal transplantation. Clin Transplant (2013) 1.00
Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2012) 1.00
Grating based x-ray differential phase contrast imaging without mechanical phase stepping. Opt Express (2014) 1.00
The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol (2007) 1.00
Magnetic resonance imaging of vascular oxygenation changes during hyperoxia and carbogen challenges in the human retina. Invest Ophthalmol Vis Sci (2011) 1.00
Visual attention deficits in Alzheimer's disease: an fMRI study. Neurosci Lett (2005) 1.00
Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. J Hepatol (2010) 0.99